gaining weight on retatrutide Retatrutide: A Multi-Receptor Approach to Management is this normal weight gain

Approved in late 2024

Food and Drug Administration (FDA) has approved four GLP-1 drugs for weight loss in people with overweight or obesity: liraglutide (Saxenda) orforglipron (Foundayo) semaglutide (Wegovy) tirzepatide (Zepound) Liraglutide, semaglutide, and tirzepatide are injectable medications that come in prefilled pens

These mechanisms havent been investigated in humans [57]

Compounded GLP-1 medications may be prescribed by a range of independent licensed healthcare professionals, including nurse practitioners, general practitioners, endocrinologists, family medicine physicians, and diabetes management specialists, among others

It is important to note that B12 injections are not licensed or indicated for weight loss purposes in the UK